Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Biosign Technologies's Enterprise Value is C$0.11 Mil.
Biosign Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2015 was C$0.93 Mil. Therefore, Biosign Technologies's EV-to-EBIT ratio for today is 0.12.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Biosign Technologies's Enterprise Value is C$0.11 Mil.
Biosign Technologies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 was C$2.33 Mil. Therefore, Biosign Technologies's EV-to-EBITDA ratio for today is 0.05.
Biosign Technologies Enterprise Value Historical Data
The historical data trend for Biosign Technologies's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biosign Technologies's Enterprise Value
For the Health Information Services subindustry, Biosign Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biosign Technologies's Enterprise Value Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Biosign Technologies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Biosign Technologies's Enterprise Value falls into.
Biosign Technologies Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Biosign Technologies's Enterprise Value for the fiscal year that ended in Dec. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biosign Technologies (TSXV:BIO.H) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Biosign Technologies's current Enterprise Value is C$0.11 Mil.
Biosign Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.93 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Biosign Technologies's current Enterprise Value is C$0.11 Mil.
Biosign Technologies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.33 Mil.
Biosign Technologies's current Enterprise Value is C$0.11 Mil.
Biosign Technologies's Revenue for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biosign Technologies Enterprise Value Related Terms
Thank you for viewing the detailed overview of Biosign Technologies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Biosign Technologies (TSXV:BIO.H) Business Description
Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:BIO.H has been successfully added to your 